|
UPN
|
Age/sex
|
Disease
|
Duration of lung disease (months)
|
Medication at presentation
|
FVC/DLCO
|
|---|
|
1
|
77/M
|
RA-UIP
|
0
|
No therapy
|
75.3/47.2
|
|
2
|
71/F
|
RA-UIP
|
12
|
PDN/AZA/NAC
|
68.7/22.1
|
|
3
|
75/F
|
RA-UIP
|
0
|
No therapy
|
89.7/34.8
|
|
4
|
72/M
|
RA-UIP
|
0
|
MTX-LEFLUNEMIDE*
|
119.3/68.4
|
|
5
|
76/F
|
RA-UIP
|
6
|
PDN/AZA/NAC
|
82.8/60.1
|
|
6
|
50/F
|
RA-UIP
|
12
|
PDN/AZA/NAC
|
94.5/49.6
|
|
7
|
81/F
|
RA-UIP
|
0
|
No therapy
|
76.5/32
|
|
8
|
74/M
|
IPF
|
0
|
No therapy
|
70/70
|
|
9
|
78/M
|
IPF
|
0
|
No therapy
|
41.6/25
|
|
10
|
82/M
|
IPF
|
0
|
No therapy
|
75.6/38.5
|
|
11
|
85/M
|
IPF
|
0
|
No therapy
|
88/31
|
|
12
|
70/M
|
IPF
|
0
|
No therapy
|
83/58
|
|
13
|
72/M
|
IPF
|
0
|
No therapy
|
75/45
|
- Abbreviations: PDN: prednisolone, MTX: methotrexate, AZA: azathioprine, NAC: N-acetyl-cysteine, UPN: unique patient number.
- * The patient was on treatment for Rheumatoid Arthritis.
